Top 50 Life Science VC Funds & Investors in Asia (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Prox Ventures
VC Fund
|
9 | China, United States, United Kingdom | Seed, Series A | Medical, Biotechnology, Health Care | $1.9M–$28M |
|
Mitsubishi UFJ Capital
VC Fund
|
6 | Japan, United States, Singapore | Series A, Series B | Information Technology, Software, Health Care | $2M–$397M |
|
Hillhouse Investment
VC Fund
|
6 | China, United States, Singapore | Series B, Series A, Series C | Biotechnology, Health Care, Software | $2.9M–$230M |
|
Qiming Venture Partners
VC Fund
|
6 | China, United States, Hong Kong | Series B, Series A, Series C | Health Care, Biotechnology, Medical | $5M–$142M |
|
HSG
VC Fund
|
5 | China, United States, Hong Kong | Series A, Series B, Series C | Health Care, Biotechnology, Software | $4.4M–$214M |
|
SMBC Venture Capital
VC Fund
|
5 | Japan, United States, Singapore | Series A, Series B | Information Technology, Health Care, Software | $5.5M–$425M |
|
Linear Capital
VC Fund
|
5 | China, Singapore, Switzerland | Seed, Angel, Series A | Artificial Intelligence, Software, Manufacturing | $1.4M–$122M |
|
Baidu Ventures
VC Fund
|
4 | China, United States, Singapore | Series A, Seed, Series B | Artificial Intelligence, Health Care, Biotechnology | $1.4M–$145M |
|
Miyako Capital
VC Fund
|
4 | Japan, United States, United Kingdom | Series A, Seed, Series B | Medical, Biotechnology, Information Technology | $5.6M–$3B |
|
EFung Capital
VC Fund
|
4 | China, United States, India | Series A, Series B, Series C | Health Care, Biotechnology, Medical | $1.4M–$130M |
|
Osaka University Venture Capital
VC Fund
|
4 | Japan | Seed, Series A | Biotechnology, Health Care, Manufacturing | $7.1M–$142M |
|
UntroD Capital
VC Fund
|
4 | Japan, Singapore, Austria | Seed, Series A | Manufacturing, Biotechnology, Medical | $2M–$241M |
|
Nissay Capital
VC Fund
|
4 | Japan, United States, Ethiopia | Seed, Series A | Health Care, Information Technology, Medical | $709k–$77M |
|
Huagai Capital
VC Fund
|
4 | China, United States, Germany | Series A, Series B, Angel | Health Care, Biotechnology, Medical | $425k–$90M |
|
MiraclePlus
VC Fund
|
3 | China, United States, Singapore | Seed, Angel, Pre-Seed | Artificial Intelligence, Software, Information Technology | |
|
Anzu Partners
VC Fund
|
3 | United States, Canada, Spain | Series A, Series B | Biotechnology, Software, Manufacturing | |
|
Northern Light Venture Capital
VC Fund
|
3 | China, United States, South Korea | Series A, Series B, Seed | Health Care, Medical, Biotechnology | $1.3M–$100M |
|
BioVenture
VC Fund
|
3 | China, United States, Hong Kong | Series A, Series B, Seed | Health Care, Medical, Biotechnology | $1.6M–$73M |
|
Legend Capital
VC Fund
|
3 | China, United States, South Korea | Series B, Series A, Series C | Health Care, Medical, Biotechnology | $2.8M–$200M |
|
Angel Bridge
VC Fund
|
3 | Japan | Series A, Seed | Information Technology, Software, Consulting | $746k–$170M |
|
DG Daiwa Ventures
VC Fund
|
3 | Japan, United States, India | Seed, Series A | FinTech, Software, Internet | $679k–$142M |
|
CITIC Capital Holdings
VC Fund
|
3 | China, United States, Japan | Series A, Series B, Series C | Manufacturing, Health Care, E-Commerce | $2.8M–$230M |
|
Entrepreneurship Relay Group
VC Fund
|
3 | China | Series A, Angel | Manufacturing, Software, Enterprise | $222k–$27M |
|
ASBV
VC Fund
|
3 | China, Australia, Hong Kong | Seed, Series A, Angel | Health Care, Medical, Biotechnology | $425k–$31M |
|
Keio Innovation Initiative
VC Fund
|
3 | Japan, United Kingdom | Series A, Seed | Medical, Health Care, Biotechnology | $1.5M–$213M |
|
Senshu Ikeda Capital
VC Fund
|
3 | Japan | Series A, Seed | Software, Manufacturing, Internet | $1.5M–$142M |
|
WuXi AppTec
VC Fund
|
3 | United States, China, Israel | Series A, Series B, Series C | Biotechnology, Pharmaceutical, Health Care | $6M–$130M |
|
Vinno Capital
VC Fund
|
3 | China, United States | Series A, Seed, Series B | Manufacturing, Semiconductor, Hardware | $1.4M–$142M |
|
CD Capital
VC Fund
|
3 | China, United States | Series A, Series B, Seed | Health Care, Biotechnology, Medical Device | $1.4M–$34M |
|
SBI Investment
VC Fund
|
3 | Japan, South Korea, United States | Series B, Series A | Software, Information Technology, Financial Services | $4.8M–$283M |
|
Mizuho Capital
VC Fund
|
3 | Japan, United States, China | Series A, Series B | Information Technology, Software, Internet | $2.7M–$850M |
|
JAFCO
VC Fund
|
3 | Japan, United States, Israel | Series A, Series B | Information Technology, Software, Artificial Intelligence | $2.7M–$298M |
|
ZSVC
VC Fund
|
3 | China, United States, India | Series A, Seed, Series B | Manufacturing, Medical, Health Care | $1.4M–$85M |
|
Nippon Venture Capital
VC Fund
|
3 | Japan, United States, Indonesia | Series A, Series B | Software, Health Care, Medical | $3M–$425M |
|
Hillhouse Ventures
VC Fund
|
3 | China, Singapore, Norway | Series A, Series B, Seed | Manufacturing, Biotechnology, Health Care | $10M–$120M |
|
Tianjin Venture Capital
VC Fund
|
3 | China, United States | Seed, Series A | Manufacturing, Information Technology, Biotechnology | $202k–$28M |
|
ULTIMA
VC Fund
|
3 | China | Angel, Series A | Hardware, Software, Agriculture | $1.6M–$14M |
|
Bits x Bites
VC Fund
|
2 | China, Israel, Singapore | Series A, Seed, Series B | Biotechnology, Food and Beverage, Food Processing | |
|
Sherpa Healthcare Partners
VC Fund
|
2 | China, United States, Kenya | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $2.8M–$156M |
|
Oriental Fortune Capital
VC Fund
|
2 | China, United States | Series A, Series B, Seed | Software, Manufacturing, Information Technology | $1.4M–$100M |
|
Puhua Capital
VC Fund
|
2 | China, United Kingdom, United States | Series A, Series B, Seed | Health Care, Medical, Manufacturing | $1.4M–$112M |
|
CentreGold Capital
VC Fund
|
2 | United States, China, Canada | Seed, Series A, Angel | Medical Device, Internet, Health Care | |
|
Gaw Capital Partners
VC Fund
|
2 | China, Singapore, United States | Series A, Series C, Seed | Real Estate, Property Management, Hospitality | |
|
Haitang Fund
VC Fund
|
2 | China | Seed, Series A | Manufacturing, Biotechnology, Medical | |
|
UTEC - The University of Tokyo Edge Capital Partners
VC Fund
|
2 | Japan, United States, India | Seed, Series A | Health Care, Biotechnology, Medical | $3.1M–$85M |
|
Huimei Capital
VC Fund
|
2 | China, United States, Japan | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $10M–$227M |
|
Shunwei Capital
VC Fund
|
2 | China, United States, India | Series A, Series B, Series C | Manufacturing, Software, Internet | $1.4M–$130M |
|
BOHE Angel Fund
VC Fund
|
2 | China | Angel, Series A, Seed | Health Care, Medical, Biotechnology | $1.4M–$100M |
|
Alibaba Entrepreneurs Fund
VC Fund
|
2 | Hong Kong, Taiwan, United States | Series A, Seed, Series B | Software, E-Commerce, Artificial Intelligence | $510k–$150M |
|
Eisai
VC Fund
|
2 | Japan, United States, China | Series A, Series C | Biotechnology, Health Care, Medical | |
| Access all 50 VC funds in Asia Life Science startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.
Show more...Investment focus
- Industry: Medical, Biotechnology, Health Care
- Stage:Seed, Series A
- Geography: China, United States, United Kingdom
Investor stats
- Total investments: 73
- Round size: Seed $1.9M–$5.6M; Series A $2.8M–$28M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- DotBio — DotBio is a biopharmaceutical company specialized in next-generation domain antibody therapies.
- Brise Pharma — Brise Pharma operates in the scientific research and technical service industry.
- Coastar Therapeutics — Coastar Therapeutics develops an erythrocyte enveloped virus delivery technology platform to perform repeated virus dosing. It evades recognition and attack by the immune system to address the challenges of systemic and repeated administration of drug therapies. Coastar's process technology and “red blood cell membranes only” enable thecompany to overcome the challenges of mass production and standardization, and has cost advantages. The company's first product targets oncolytic viruses and is developing ELCV solutions for other therapies.The company was founded in 2017 and is based in San Diego, CAlifornia.
Mitsubishi UFJ Capital is a venture capital firm focusing on life science, ICT, and high technology investments.
Show more...Investment focus
- Industry: Information Technology, Software, Health Care
- Stage:Series A, Series B
- Geography: Japan, United States, Singapore
Investor stats
- Total investments: 479
- Round size: Series A $2M–$113M; Series B $6.4M–$397M
- Lead/follow: 5% lead, 95% follow
- Last fund: May invest from a new fund soon — raised $1.4B in 2020
Portfolio highlights
- Diggle — DIGGLE is a service that provides fundamental management accounting management on the cloud called fraud management. It is possible to reduce the mistakes and man-hours of the fraud management task and easily carry out the fraud management task even if it is not an expert in finance or accounting.DIGGLE covers budget creation work and budgetrecord comparison work, especially in the foreman management work. In the budget creation work, the KPI and the budget are automatically created by inputting the target numerical value to the preset parameters utilizing the budget generator function, while the forecast contrasting work is made up of the financial information, non-financial information It is easy to calculate by simply entering the numerical value, and it is possible to carry out calculation of the forecast contrast.
- Japan Agriculture — Exportation of Japanese agricultural products is currently small in volume. While Japanese farmers aspire to export their products to foreign countries for more people to enjoy and local consumers universally share the positive perception of the quality of Japanese agricultural products, issues such as price, communication, and logistics hinder theexpansion of exportation.They aim to solve these issues and satisfy the needs of both Japanese farmers and global consumers which are so clearly evident but devastatingly unmet.
- Japan Culture and Technology — Japan Culture and Technology assists artists and craftspeople in expanding their activities by providing IT support.
Founded in 2005, Hillhouse is a leading global investment management firm, active across public equity, private equity, real estate and private credit. The firm invests over a long-term horizon and partners with exceptional entrepreneurs to deliver sustainable value creation for quality companies.Hillhouse is a full life-cycle private equityfirm, investing for the long term across opportunities in the healthcare, business services, consumer, and industrials sectors. The firm manages capital on behalf of global institutions such as non-profit foundations, endowments, and pensions.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Series B, Series A, Series C
- Geography: China, United States, Singapore
Investor stats
- Total investments: 331
- Round size: Series A $2.9M–$142M; Series B $14M–$230M; Series C $15M–$220M
- Lead/follow: 38% lead, 62% follow
- Last fund: May invest from a new fund soon — raised $11B in 2018
Portfolio highlights
- Sainte — Sainte is a company which provides professional nutritional solutions for babies with different nutritional needs
- Vita Dynamics — Vita Dynamics involves learning through real-world interactions by developing robots that can physically engage with their environment, they can adapt more naturally and efficiently.
- Horizon Continental Technology — Horizon Continental Technology is a joint venture between Continental Group and Horizon Robotics
Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companiesin the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series B, Series A, Series C
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 730
- Round size: Series A $5M–$64M; Series B $10M–$100M; Series C $15M–$142M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely still investing — raised $887M in 2023
Portfolio highlights
- Duet — Duet is a dating application helps you find meaningful relationships based on shared interests and experiences.
- Galaxy Bot — Galaxy Bot is an innovative robotics company that provides intelligent universal service robotic products.
- SPEEDIANCE — Speediance specializes on smart self-serviced gym equipment. The company develops smart fitness equipment and an online platform to provide training guidance and courses about strength training, enabling individual users to connect with the workout community and have better home workout experiences.
We help founders build enduring companies.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Series A, Series B, Series C
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 751
- Round size: Series A $4.4M–$100M; Series B $12M–$200M; Series C $26M–$214M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- MarqVision — Effortlessly discover and remove counterfeits to protect your sales and reputation.
- Midas — Midas is the first neobroker of Turkey, providing zero commission Turkish and American stocks.
- Yunzhou Zhiwei — Yunzhou Zhiwei is a high-tech startup focused on serving large-scale equipment maintenance industries such as aviation, aerospace, shipbuilding, and rail transit. It leverages smart maintenance concepts and advanced digital technologies to make complex equipment maintenance more efficient and lean. The company drives industrial transformationtoward intelligent maintenance, helping enterprises enhance growth, efficiency, and operational excellence.
Sumitomo Mitsui Banking Corporation (SMBC) and its group companies offer a broad range of financial services centered on banking. They are also engaged in the leasing, securities, credit card, investment, mortgage securitization, venture capital and other credit related businesses. The following lists the activities of SMBC, its subsidiaries andaffiliates in the various business segments.
Show more...Investment focus
- Industry: Information Technology, Health Care, Software
- Stage:Series A, Series B
- Geography: Japan, United States, Singapore
Investor stats
- Total investments: 497
- Round size: Series A $5.5M–$170M; Series B $6.4M–$425M
- Lead/follow: 3% lead, 97% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- PLUGO — PLUGO provides ever-evolving "hospitality services" suitable for the future EV era, combining products & digital technology unique to IoT.
- Letara — Letara operates a space technology platform with the intention to serve a logistics network covering the solar system. The company produces hybrid propulsion engines for small spacecraft, promoting groundbreaking advances in space propulsion with high thrust, safe, and inexpensive propulsion system technology.
- M&A Bazaar — M&A Bazaar provides the M&A Bazaar Method, a revolutionary M&A process that systematically solves the challenges encountered by traditional M&A procedures.
Linear Capital is a Frontier Tech Fund founded in 2014 by Harry Wang, Facebook's first Chinese R&D manager. We currently manage 10 funds with AUM of more than $2 billion.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Manufacturing
- Stage:Seed, Angel, Series A
- Geography: China, Singapore, Switzerland
Investor stats
- Total investments: 85
- Round size: Seed $1.4M–$120M; Angel $1.4M–$122M; Series A $5.7M–$50M
- Lead/follow: 32% lead, 68% follow
- Last fund: Likely still investing — raised $500M in 2021
Portfolio highlights
- NewPro — NewPro is in the process of increasing production and establishing regulations for lactoferrin raw materials, with the goal of bringing the product to market as quickly as feasible.
- Juehua Medical — Juehua Medical is a medical technology company focusing on the field of visual health.
- Deepin Technology — Deepin Technology is a company that utilizes artificial intelligence, quantum chemistry, and high-throughput experiment technologies to enhance the efficiency and workflow of chemical material innovation. it offers efficient R&D solutions for chemical materials, aiming to solve lab bottlenecks, promote innovative research, and enhance customervalue.
Doma Protocol is a purpose-built blockchain to modernize and unlock the liquidity of over 362M existing and future domains
Show more...Investment focus
- Industry: Artificial Intelligence, Health Care, Biotechnology
- Stage:Series A, Seed, Series B
- Geography: China, United States, Singapore
Investor stats
- Total investments: 204
- Round size: Seed $1.9M–$28M; Series A $1.4M–$42M; Series B $8M–$145M
- Lead/follow: 24% lead, 76% follow
Portfolio highlights
- AMP — AMP Robotics creates a scalable robotic system that reduces the cost of recycling and enables smart recycling facilities. AMP Robotics' solution is a combination of computer vision and machine learning with robots that can identify and rapidly pick recyclable materials off a conveyor belt for market and recovery.AMP Robotics automates theidentification, sorting, and processing of material streams to extract value for material recovery facilities (MRFs) that process municipal solid waste, construction and demolition, e-waste, and auto-shredding. The company's engineering design reduces the cost of capital investment with modular implementation easily dropping into existing facility infrastructure without costly retrofits or interruption to operations.AMP Robotics was founded on 2015 and is headquartered in Louisville, Colorado.
- Fastlane — We take innovative brands global. Fastlane is a full-service D2C solutions provider that assists enterprises with brand development, business infrastructure, and sales creation/growth in European, North American and Asian markets. We offer a superior one-stop solution, with expertise in go-to-market strategy, traditional and digital marketing,PR, logistics, e-commerce, sales, and platform development. We work with companies big and small, and our custom-tailored solutions range in scope from basic consulting services to 360° turnkey operations.
- Automation Hero — Reduce your company's document processing time with an intelligent automation platform that's simple, secure, and accurate.
Miyako Capital is the venture capital that manages Kyoto University 2nd Venture Fund (KUVF). The company was founded in 2013 and based in Kyoto & Tokyo, Japan. Investment fields are: 1) Life Science, Biotechnology: Drug creation, regenerative medicine, medical beauty equipment, medical services.2) Agri-Food: Industrialization,agricultural and fishery products growth-promoting technology, specified health food, health food.3) Environment, Energy: Alternative energy, and related technologies.4) IT, Electronics: Web, mobile related devices and application, telecommunication technology, security, consumer and business oriented application, mechatronic, robot.5) New services utilizing state-of-art technology.Investment stages: Primary investment stages are initial-growth stages of seed and early. However, we aim at all growth stages and make investment in post-IPO portfolio companies as well as public companies that are related with Kyoto University.
Show more...Investment focus
- Industry: Medical, Biotechnology, Information Technology
- Stage:Series A, Seed, Series B
- Geography: Japan, United States, United Kingdom
Investor stats
- Total investments: 52
- Round size: Seed $5.6M–$118M; Series A $6.1M–$70M; Series B $99M–$3B
- Lead/follow: 19% lead, 81% follow
- Last fund: May invest from a new fund soon — raised $1.4B in 2019
Portfolio highlights
- Flosfia — FLOSFIA is a spin-off from a research of Kyoto University, specializing in film-formation by mist chemical vapor deposition (CVD). Making use of physical properties of gallium oxide (Ga2O3), FLOSFIA has devoted to development of low-loss power devices.
- VLP Therapeutics — VLP Therapeutics, LLC (VLP) was established in 2012 by seasoned biopharmaceutical veterans with mission to develop innovative medical treatment which transforms traditional vaccine and targeted antibody therapies to address global unmet medical needs. Its vision is to combat the 21st century global public health problems through revolutionary nextgeneration i-αVLP (inserted alpha VLP) Technology. The company is headquartered in Gaithersburg, Maryland
- XFOREST Therapeutics — xFOREST Therapeutics develops a drug discovery platform that targets RNA structures.
Shenzhen EFUNG Investment Management Enterprise L. P. is one of China's earliest institutions investing in professional biomedical industries. Their strong research team and great investment returns made us won 'The Most Pioneering VC Institution” 'The Most Dynamic Pharmaceutical VC Institution in China' and 'The Top Ten VCInstitutions in Shenzhen'. With this influence, EFUNG has drawn a lot of attention from the medical and life science industry. And it is interviewed by Nature, which is the most authoritative science magazine in the world. Over a decade of years, they have been focusing on the medical and health industry, especially the VC and PE investment business of novel drugs and high-end medical devices. The mission of EFUNG is to drive the industrialization of medical researches by capital and to gain rich returns to investors. EFUNG has deeply screened and invested in more than 20 domestic and international premium enterprises, such as Chipscreen Biosciences, Frontier Biotechnologies, Ascentage Pharma, Lifotronic, Aridis Pharmaceuticals, and Centrexion.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Series C
- Geography: China, United States, India
Investor stats
- Total investments: 63
- Round size: Series A $1.4M–$76M; Series B $14M–$113M; Series C $14M–$130M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Ruijiakang — Ruijiakang focuses on the research, development, and application of green synthetic biology production, as well as the layout and research of biofuels and biomaterials for non-grain anaerobic organic alkyd pipelines, and employs Zymomonas mobilis.
- Huiguan Biology — Huiguan Biology is a developer of super-resolution microscopes for in vivo drug screening.
- JGene Biotechnology — JGene Biotechnology is a research and development biotechnology company dedicated to the research and development of universal CAR-NK/T products from iPS. It is hoped that the large-scale production of CAR-NK/T from iPS will provide cancer patients with spot-type, price-friendly, and affordable new immune cell therapy products. Recentlyreceived angel round investment.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Osaka University Venture Capital is a venture capital firm that focuses on early-stage ventures in the fields of life innovation, green innovation, and platform technology. The firm was founded in 2014 and based in Osaka, Japan.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Manufacturing
- Stage:Seed, Series A
- Geography: Japan
Investor stats
- Total investments: 78
- Round size: Seed $7.1M–$99M; Series A $16M–$142M
- Lead/follow: 35% lead, 65% follow
Portfolio highlights
- QunaSys — Quantum physics is a relatively new field built since the beginning of the 20th century, but we have used MRI (nuclear magnetic resonance equipment) and lasers used for close examinations in hospitals, and semiconductors mounted on computers. Supports the technology that supports the daily life of people.QunaSys was established to bring out thequantum physics that has been active behind the scenes to the front stage, and to make use of quantum properties to realize technologies that could not be achieved with existing technologies.
- Thinker — Thinker provides sales of proximity sensors and proposed solutions using these products.
- Celaid Therapeutics — Celaid Therapeutics specializes in manufacturing and sales of regenerative medicine products utilizing human hematopoietic stem cells.
UntroD Capital is an R&D-based innovative technology that specializes in social implementation.
Show more...Investment focus
- Industry: Manufacturing, Biotechnology, Medical
- Stage:Seed, Series A
- Geography: Japan, Singapore, Austria
Investor stats
- Total investments: 120
- Round size: Seed $2M–$43M; Series A $2.1M–$241M
- Lead/follow: 38% lead, 62% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- CastBio — Castbio specializes in antibody-drug conjugate-based drug discovery research and development. Along with medications, it also creates research reagents, medical equipment, in vitro diagnostic items, and offers drug discovery consulting.
- Illumi Medical — Illumi Medical is a manufacturing company that produces medical equipment and devices for the healthcare sector.
- Reborna Biosciences — Reborna Biosciences provides research and development in the field of genetic diseases. The company develops therapeutic options for area of unmet medical needs in genetic rare disease. The company's technology enables low-molecular compounds to target ribonucleic acid. The company provides new disease-modifying drugs for patients sufferingfrom rare genetic diseases including spinal muscular atrophy.
Nissay Capital is a venture capital Company specializing in seed, start-up, growth capital, middle stage, and later stage investment.
Show more...Investment focus
- Industry: Health Care, Information Technology, Medical
- Stage:Seed, Series A
- Geography: Japan, United States, Ethiopia
Investor stats
- Total investments: 237
- Round size: Seed $709k–$43M; Series A $2.7M–$77M
- Lead/follow: 26% lead, 74% follow
Portfolio highlights
- AstroX — AstroX is a private space startup company that develops satellite launch vehicles for space development. It utilizes the rockoon method for developing launch vehicles and small rockets to help clients easily use space.
- ZIRITZ — StockFormer is a real estate investment platform that connects investors with property opportunities. Users can calculate their asset score and gain a better understanding of their position and status as an investor, as well as their creditworthiness to financial institutions, among other things. Investors can exchange information on purchased andsold properties, as well as loan terms. The log provides investors with an understanding of the current real estate market conditions, investment conditions, and loan conditions that correspond to their asset formation level, allowing them to make appropriate investment decisions.
- CREO Bioscience — Cleo Bioscience is a Biotechnology company.
Huagai Capital is a private equity investment firm that invests in start-up or growth companies in the areas of healthcare, TMT, and culture.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Angel
- Geography: China, United States, Germany
Investor stats
- Total investments: 131
- Round size: Angel $425k–$15M; Series A $1.4M–$63M; Series B $3.5M–$90M
- Lead/follow: 42% lead, 58% follow
- Last fund: May invest from a new fund soon — raised $430M in 2018
Portfolio highlights
- AccuMedical — AccuMedical is a full-line product company in the field of neurological intervention, headquartered in Beijing with an R&D center located in California. It develops and produces medical device products for the treatment of aneurysms, preventing, and treating bleeding diseases caused by the rupture of vascular aneurysms.
- PrinoPharma — PrinoPharma focuses on developing novel druggable sites targeting difficult-to-drug or existing druggable targets.
- Argo Biopharma — Bowang Pharmaceutical is an RNAi drug research and development platform focused on siRNA drug development.
MiraclePlus invests in and accelerates early-stage startups. MiraclePlus assists startups in developing products that are good enough to succeed in the market. MiraclePlus' acceleration program works with the founders to get each team in top shape so that they can present to thousands of investors on Demo Day.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Information Technology
- Stage:Seed, Angel, Pre-Seed
- Geography: China, United States, Singapore
Investor stats
- Total investments: 76
- Lead/follow: no public data
Portfolio highlights
- TestSprite — AI powered fully automated end-to-end testing solutions to help enterprises launch their products faster.
- Excellent Vision — Excellent Vision is a spatial intelligence company focused to transforming video creation into a 4D world model, enabling AI big models to grasp, generate, and reason about 4D space.
- Gongji Technology — Gongji Technology is an idle computing power sharing platform that combines distributed computing power with leading scheduling techniques to address elastic computing power requirements.
Anzu Partners is an investment firm that focuses on industrial and life science technology companies with the potential to transform their industry. Anzu's portfolio support platform is dedicated to drive results beyond our initial investment and establish long-term relationships. We team with entrepreneurs to develop and commercializetechnological innovations by providing capital and deep expertise in business development, market positioning, global connectivity, and operations. .Co-founders Whitney Haring-Smith, David Michael, and David Seldin launched the firm in 2014 in Washington, District of Columbia.
Show more...Investment focus
- Industry: Biotechnology, Software, Manufacturing
- Stage:Series A, Series B
- Geography: United States, Canada, Spain
Investor stats
- Total investments: 75
- Lead/follow: no public data
Portfolio highlights
- 6K — WHERE INDUSTRY 4.0 MEETS SUSTAINABLE PRODUCTION OF BREAKTHROUGH MATERIALS
- e-Zinc — Founded in 2012, e-Zinc is a Toronto, Canada, based corporation that has developed a breakthrough electrochemical technology for storing energy in zinc metal. This low-cost, flexible, and long-duration energy storage solution will provide the platform for the world’s energy markets to be fully powered by renewable energy, enabling a zero-carbonenergy future.
- CytoTronics — Visualize live cell function at scale for cell biology discovery with Pixel systems. Monitor cell viability, morphology, electrophysiology, metabolism and more.
Supporting the next generation of entpreneurs in enterprise, healthcare, and consumer with disruptive potential.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: China, United States, South Korea
Investor stats
- Total investments: 237
- Round size: Seed $1.3M–$100M; Series A $4.3M–$40M; Series B $11M–$62M
- Lead/follow: 28% lead, 72% follow
- Last fund: Likely still investing — raised $375M in 2021
Portfolio highlights
- VOC AI — VOC AI offers AI tools for ecommerce insights and customer service solutions.
- RootData — RootData operates as a Web3 asset data platform that pioneers in encapsulating both on-chain and off-chain data of Web3 assets.
- Spiro Medical — Spiro Medical is revolutionizing the treatment paradigm for patients with severe, chronic airway diseases.
Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 156
- Round size: Seed $1.6M–$20M; Series A $1.9M–$42M; Series B $3M–$73M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- CART Medical — CART Medical Technologies, Ltd. is a high-tech company specializing in the development and application of new technologies for immune cell therapy. It has a 2,200 square meter GMP laboratory and research and development laboratory.
- Ruoyi Biotech — Ruoyi Biotech is a developer of macromolecular drug delivery technology.
- Yili Pharmaceutical — Yili Pharmaceutical is a pharmaceutical R&D company that mainly engages in biochemical product technology R&D, medical research and experimental development, engineering and technology research and experimental development, and software development.
Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China.Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in Chinaor on markets related to China.Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services.Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc.As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series B, Series A, Series C
- Geography: China, United States, South Korea
Investor stats
- Total investments: 378
- Round size: Series A $2.8M–$94M; Series B $12M–$113M; Series C $14M–$200M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely still investing — raised $177M in 2021
Portfolio highlights
- Z.ai — Z.ai develops artificial intelligence models and services built upon large-scale pretrained architectures. The company offers ChatGLM, a dialogue-focused language model series designed for smooth conversation and easy integration. It also provides Ying, a text-to-video model capable of generating short video clips from text or images, and AutoGLM,a voice-driven AI agent that performs smartphone tasks based on complex user instructions. Z.ai supports integration through an API platform and offers migration assistance for developers moving from other AI ecosystems. The company’s technology stems from research at Tsinghua University’s KEG lab and emphasizes general-purpose cognitive intelligence models.
- Pony.ai — Pony.ai is a startup that builds full-stack autonomous driving solutions. It is a pioneer in autonomous mobility technologies and services across the US and China, spearheading public-facing Robotaxi pilots in both markets. Pony.ai is committed to creating a safe and sustainable mobility future by delivering autonomous mobility everywhere.Thecompany was founded by James Peng and Tiancheng Lou in 2016 and is headquartered in Fremont, California, United States.
- Volant Aerotech — Volant Aerotech is a company specializing in the R&D, manufacturing, and service of passenger eVTOL, an electric vertical take-off and landing aircraft.
Angel Bridge is a angel investor groups in Japan and provide high quality and abundant funds to excellent companies.
Show more...Investment focus
- Industry: Information Technology, Software, Consulting
- Stage:Series A, Seed
- Geography: Japan
Investor stats
- Total investments: 58
- Round size: Seed $2.2M–$113M; Series A $746k–$170M
- Lead/follow: 36% lead, 64% follow
- Last fund: May invest from a new fund soon — raised $152M in 2019
Portfolio highlights
- Emole — Emole is a platform that connects content creators with viewers through short drama content, offering a variety of engaging stories.
- Loglass — Loglass offers corporate intelligence to enhance business management.
- Plainer — Plainer is an IT company that provides software development, data management, and SaaS solutions.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!DG Daiwa Ventures invests in start-up companies with next-generation technology and provides business development support. It is focused on blockchain, xR, AI, security, and BioHealth, as they are likely to be at the foundations of future businesses. In addition to the five core technologies, the fund will also focus on IoT technologies, whichoften overlap or serve as an application layer.
Show more...Investment focus
- Industry: FinTech, Software, Internet
- Stage:Seed, Series A
- Geography: Japan, United States, India
Investor stats
- Total investments: 68
- Round size: Seed $679k–$26M; Series A $4M–$142M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- digzyme — Digzyme is a research and development platform for creating, discovering, and evaluating new enzyme-catalyzed reactions by bioinformatics.
- MyDearest — MyDearest is a Full dive product planning and development company
- Acompany — Acompany provides products and consulting development related to secret computing.
CITIC Capital Holdings is an alternative investment management and advisory company headquartered in China.
Show more...Investment focus
- Industry: Manufacturing, Health Care, E-Commerce
- Stage:Series A, Series B, Series C
- Geography: China, United States, Japan
Investor stats
- Total investments: 99
- Round size: Series A $3M–$230M; Series B $2.8M–$50M; Series C $4.3M–$220M
- Lead/follow: 38% lead, 62% follow
- Last fund: May invest from a new fund soon — raised $2.8B in 2018
Portfolio highlights
- NEON — Discover a global experience entertainment company specialising in unique, immersive and large-scale experiences held all around the world, all year round.
- Healthy Tree — Healthy Tree is a comprehensive solution provider for self-medication devices.
- Regional Fish — Regional Fish provides seed, seedlings, aquaculture methods and fisheries services.
Entrepreneurship Relay Group manages a fund of more than 4 billion yuan, directly or indirectly.
Show more...Investment focus
- Industry: Manufacturing, Software, Enterprise
- Stage:Series A, Angel
- Geography: China
Investor stats
- Total investments: 24
- Round size: Series A $222k–$27M
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- Songying Technology — Songying Technology focuses on the research and development of cloud-native real-time 3D engines and graphics collaboration platforms.
- Spectral Domain Technology — Spectral Domain Technology is a provider of 5G low-orbit broadband terminals, supplying operators, industrial Internet companies, satellite Internet, and government and enterprise customers with ocean communication needs.
- Optical Standard Technology — Optical Standard Technology focuses on the design and manufacture of optical computing chips and optical computing boards for use in scenarios requiring large amounts of AI computing power, such as large model reasoning and training, autonomous driving, smart cities, quantitative finance, AI security.
ASBV focuses on early and mid-term venture capital investments.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Seed, Series A, Angel
- Geography: China, Australia, Hong Kong
Investor stats
- Total investments: 27
- Round size: Seed $3M–$14M; Angel $425k–$425k; Series A $1.4M–$31M
- Lead/follow: 48% lead, 52% follow
Portfolio highlights
- Kaiyue Life — Kaiyue Life focuses on small molecule medication research & development for the treatment of human Ras mutant solid tumours.
- Boundary Intelligent Control — Boundary Intelligent is specialized in creating airborne systems, such as flight control systems, that satisfy the needs of civil aircraft, as well as enhancing the ecology of the civil aviation industry and constructing aircraft perception, navigation, decision-making, and planning capabilities.
- Longyue Mechanical and Electrical Technology — Longyue Mechanical and Electrical Technology engaged in technologies, strengthened linkages, and provided commercial aircraft services.
Keio Innovation Initiative (KII) is a venture capital established by Keio University. In order to make more effective use of the research results of Keio University, we aim to contribute to the development of society by creating investment for venture companies that utilize research results and creating new industries.The key to thinking aboutJapan's future growth strategy is to utilize advanced research results of the university. In addition to GDP, in addition to GDP, Japan is the world's third largest R & D exporter in R & D expenses, but as the low growth rate shows, it has a problem in investment efficiency in research and development. There are also reports on the entrepreneurial spirit that is indispensable for creating new industries, with the lowest entrepreneurial activity rate among developed countries.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Series A, Seed
- Geography: Japan, United Kingdom
Investor stats
- Total investments: 79
- Round size: Seed $1.5M–$213M; Series A $7.4M–$155M
- Lead/follow: 28% lead, 72% follow
- Last fund: May invest from a new fund soon — raised $1.4B in 2020
Portfolio highlights
- Neusignal Therapeutics — Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses.
- Optieum Biotechnologies — Optieum Biotechnologies Inc. is a pre-clinical stage biotechnology company committed to developing innovative scFv antibody-based therapies for the treatment of patients with cancers. Their proprietary platform technology, Eumbody System™, enables to develop and detect a scFv-based product candidates that specifically bind to, and modulate tooptimize the immune-cell function for oncology targets.We are committed to helping patients with severe diseases by bringing life-changing therapies to the patients in need.
- Nanofiber Quantum Technologies — Discover how NanoQT builds the foundation for scalable quantum computing with nanofiber cavity-QED technology and high-fidelity quantum connectivity.
Senshu Ikeda Capital offers financial consultancy services.
Show more...Investment focus
- Industry: Software, Manufacturing, Internet
- Stage:Series A, Seed
- Geography: Japan
Investor stats
- Total investments: 64
- Round size: Seed $1.5M–$61M; Series A $1.9M–$142M
- Lead/follow: 5% lead, 95% follow
- Last fund: May invest from a new fund soon — raised $177M in 2019
Portfolio highlights
- TSK Corporation —
- Akari Hosho — Akari Hosho provides a group of trusted professionals, including lawyers and judicial scriveners. Akari Hosho provides a guarantee service.
- New Innovations — New Innovations company is offering a snuggling service to many people who support Japan's “high quality”. AI and robots do not take away the job, but robots support the work that is accomplished without the involvement of people, and many working people are aiming for the future to create a more humanoid life. With the problem of lack oftalent, it was difficult to reflect technology on OFF Line until now, trying to provide robots in the “food and drink” and “retail” industry, CEKAI's first demand forecast AI unmanned cafeThe robot “√C” was developed. √C is not “looking for coffee that suits me”, but instead realizes “coffee is perfect for me” with demand forecasting AI. Today, people who drink coffee are choosing their favorite cafe, canned coffee, convenience store coffee, etc., according to their taste needs, SPEED needs, and hospitality needs. The company developed the service as a new choice of coffee, and in the future, the perfect coffee according to the taste preferences, busy, physical condition and mood of the day., which aims to provide. In July 2019, the company receives a third party quota increase of 70 million yen from Zashid Capital and DEEPCORE. From August 1, 2019, with the cooperation of Nankai Electric Railway, “√C” will be installed at Namba Station/Namba Skyo, and demonstration experiments will begin.
WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. As an innovation-driven and customer-focused company, WuXi AppTec helps our partners improve theproductivity of advancing healthcare products through cost-effective and efficient solutions,With industry-leading capabilities such as R&D and manufacturing for small molecule drugs, cell and gene therapies, and testing for medical devices, WuXi AppTec's open-access platform is enabling more than 3,900 collaborators from over 30 countries to improve the health of those in need – and to realize our vision that "every drug can be made and every disease can be treated".
Show more...Investment focus
- Industry: Biotechnology, Pharmaceutical, Health Care
- Stage:Series A, Series B, Series C
- Geography: United States, China, Israel
Investor stats
- Total investments: 45
- Round size: Series A $6M–$90M; Series B $21M–$130M; Series C $30M–$40M
- Lead/follow: 18% lead, 82% follow
- Last fund: May invest from a new fund soon — raised $250M in 2015
Portfolio highlights
- D3 Bio — D3 Bio is a globally focused biotechnology company focusing on developing and registration of innovative medicines in oncology and immunology. At D3 Bio, our new medicine development approach is fundamentally differentiated. We do not just only start with science in the lab. First, we pinpoint the greatest unmet patient and market needs – whereexisting standard-of-care approaches yield unsatisfactory clinical outcomes. Then we take those insights into the lab to guide the identification of fit for purpose science and technology and define our drug development path.
- ShouTi — ShouTi specializes in the discovery and development of drugs against a type of targets called GPCR. The company develops drugs focused on novel small molecules for multiple unmet medical needs. ShouTi is currently operating in Stealth mode.
- Bioyond Tech — Bioyond Tech utilizes robotics and artificial intelligence technology to provide a new generation of modular products and automation solutions for the life sciences sector.
Vinno Capital focuses on early-stage venture investments in ICT and healthcare-related fields.
Show more...Investment focus
- Industry: Manufacturing, Semiconductor, Hardware
- Stage:Series A, Seed, Series B
- Geography: China, United States
Investor stats
- Total investments: 32
- Round size: Series A $1.4M–$14M; Series B $11M–$142M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Feibao Intelligent — Feibao is a high-tech enterprise that uses core technology to create a "specialized vehicle operation platform for garbage sorting and transportation". The company adheres to the core values of "willing to learn, proficient in efficiency; brave in innovation and detail", insists on R&D innovation and talent training, andpays attention to the ultimate customer service experience.
- Teyan Semiconductor — Taiyan Semiconductor is a semiconductor process and equipment service provider in the field of advanced packaging. It provides customers with advanced packaging production lines such as SiP, Fanout, Chiplet, 3D, etc. Laser (laser) + Plasma (plasma) + Sputter (coating) complete composite process and Process application equipment.
- Ruimeng Semiconductor — Ruimeng Semiconductor is a provider of intelligent human-machine interface processor chips and solutions.
CD Capital is a venture capital firm specialized in life sciences and medical technology. They are currently managing both RMB and USD funds with total size of $600M. CD Capital is operated by a professional team with diversified and profound industry backgrounds. They have made over 40 investments with high growth potential and earned a reputationas a premier venture capital firm with main focus on China healthcare industry. With broad network around China and the world, they have been able to seize the global trend, capture investment opportunities as well as help to define the future for China healthcare industry. Ultimately, they strive to grow best-in-class companies and deliver solid financial return to their investors.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Series B, Seed
- Geography: China, United States
Investor stats
- Total investments: 69
- Round size: Seed $1.4M–$14M; Series A $1.4M–$32M; Series B $7.1M–$34M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- Pipi Bear —
- Senas Medical — Senas Medical focuses on innovative cardiac electrophysiology solutions.
- Greenon Biotech — Greenon Biotech specializes in the research, development, production, and promotion of alternative antibiotic preparations for animals, which primarily include bacteriophages, probiotics, plant extracts, novel acid preparations, high-efficiency disinfectants, and so on.
SBI Investment supports the business development and growth of private venture companies through fund investment. It manages and manages venture capital funds under the management philosophy of becoming a leading company responsible for the creation and development of core industries in the 21st century as a "new industry creator".SBIInvestment has invested in a total of 986 companies in the past, of which 169 (17.1% of investment companies) have exited through IPO or M & A.
Show more...Investment focus
- Industry: Software, Information Technology, Financial Services
- Stage:Series B, Series A
- Geography: Japan, South Korea, United States
Investor stats
- Total investments: 336
- Round size: Series A $4.8M–$170M; Series B $5.9M–$283M
- Lead/follow: 23% lead, 77% follow
- Last fund: May invest from a new fund soon — raised $1.1B in 2020
Portfolio highlights
- TopoLogic — TopoLogic designs and manufactures heat flow sensors, thermoelectric conversion devices, and topological and novel spintronics materials.
- Edgecortix — At Edgecortix, we automate the design of AI accelerators for on-device deep learning. Our Dynamic Neural Accelerator IP, and performance optimized AI Software & Hardware Co-exploration framework, reduces time to market and brings massive cost savings across multiple industry verticals.
- Recho — Recho’s voice AI solutions must offer some unique features. Recho has a mission to "create the future of communication" and provides the VoiceAI platform and its application, Voice Agent.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Mizuho is the venture capital firm affiliated to Mizuho Bank, the second-largest Japanese bank in terms of assets. The firm has headquarters in Tokyo.The firm has ¥49.6 billion JPY under management, focusing on information technology and biotechnology investments. Over 600 Mizuho companies have gone public. According to Nikkei, Mizuho is thefifth-largest venture capital firm in Japan.Mizuho Capital was formed in 2002 by the merger of Fujigin Capital, Tokyo Venture Capital and IBJ Investment. Three firms were subsidiaries of Fuji Bank, Dai-Ichi Kangyo Bank and the Industrial Bank of Japan respectively.
Show more...Investment focus
- Industry: Information Technology, Software, Internet
- Stage:Series A, Series B
- Geography: Japan, United States, China
Investor stats
- Total investments: 426
- Round size: Series A $2.7M–$156M; Series B $3.8M–$850M
- Lead/follow: 4% lead, 96% follow
- Last fund: May invest from a new fund soon — raised $1.4B in 2020
Portfolio highlights
- Lavol —
- Soxai — Soxai manufactures rings for healthcare purposes using IoT.
- Enerbank Japan — Enerbank is a development and operation of electric power auction system.
Since its founding in 1973, JAFCO has always worked with leading-edge entrepreneurs. The total capital commitments of its investment funds in Japan and overseas have exceeded 1 trillion yen and the number of portfolio IPOs to date has reached over 1,000. In addition to venture investment, JAFCO also carries out buyout investment and commit to thecreations of innovative technologies and services worldwide. As entrepreneurs’ closest partner in bringing their visions to life, JAFCO provides support in areas of HR, marketing/ sales, and back-office operations, in addition to providing financing.
Show more...Investment focus
- Industry: Information Technology, Software, Artificial Intelligence
- Stage:Series A, Series B
- Geography: Japan, United States, Israel
Investor stats
- Total investments: 265
- Round size: Series A $2.7M–$255M; Series B $8.3M–$298M
- Lead/follow: 28% lead, 72% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Alxtal — Alxtal is a tech company who optimize the development, design, and manufacturing processes of the manufacturing industry with IT and AI.
- EISHIN — EISHIN is a technology company that specializes in pet tech business, recruitment consulting, website creation, and development services.
- Secondz Digital — Secondz Digital is a company that helps businesses transform using generative AI agents.
ZSVC is a Chinese venture capital firm specialized in seed and early stage investments.
Show more...Investment focus
- Industry: Manufacturing, Medical, Health Care
- Stage:Series A, Seed, Series B
- Geography: China, United States, India
Investor stats
- Total investments: 128
- Round size: Seed $1.4M–$4M; Series A $1.4M–$16M; Series B $2.8M–$85M
- Lead/follow: 27% lead, 73% follow
Portfolio highlights
- Zhicheng AI — Zhicheng AI is a developer of general-purpose artificial intelligence robots, dedicated to designing and building intelligent robotic systems that integrate advanced AI algorithms, perception technologies, and adaptive learning capabilities
- Ounuo Semiconductor — Ounuo Semiconductor is a manufacturing company that provides research and development of semiconductor equipment.
- Sunseeker — Sunseeker Power Equipment specializes in the manufacturing and supplying of garden tools, focusing on innovation in the realm of outdoor power equipment. The product range includes robotic lawn mowers, cordless Li-ion battery-powered tools, and petrol-powered equipment, catering to both garden and agricultural needs. The brand emphasizes onproviding solutions that enhance efficiency and ease of use in maintaining outdoor spaces. Sunseeker Power Equipment's offerings are designed to meet the demands of a global market, with a significant emphasis on exporting their products under the brand name 'SUNSEEKER 山科'. The company's portfolio extends to engines and a variety of garden tools series, showcasing a commitment to diversifying and expanding its product lineup to address the evolving needs of its customers.
Nippon Venture Capital ("NVCC"), established in 1996 as one of the few largest Japanese independent venture capital firms, is destined to undertake the unprecedented task of providing full-range venture capital services in cooperation with major Japanese business leaders and leading companies, which have supported and nurtured various newbusinesses on their own, as well as proactively developing new venture enterprises.
Show more...Investment focus
- Industry: Software, Health Care, Medical
- Stage:Series A, Series B
- Geography: Japan, United States, Indonesia
Investor stats
- Total investments: 159
- Round size: Series A $3M–$85M; Series B $8.2M–$425M
- Lead/follow: 15% lead, 85% follow
- Last fund: Likely still investing — raised $278M in 2023
Portfolio highlights
- Issues — Issues provides development and management of web service issues that solve the problems.
- Restore Vision — Restore Vision is a startup based in Japan aiming to develop a visual restoration gene therapy.
- Movus Technologies — Movus Technologies Indonesia is automotive company that provides car ownership rental services.
Hillhouse Venture Capital is an investment institution established by Hillhouse Capital that focuses on investing in early-stage startups.
Show more...Investment focus
- Industry: Manufacturing, Biotechnology, Health Care
- Stage:Series A, Series B, Seed
- Geography: China, Singapore, Norway
Investor stats
- Total investments: 71
- Round size: Seed $10M–$120M; Series A $10M–$85M; Series B $14M–$99M
- Lead/follow: 44% lead, 56% follow
Portfolio highlights
- RoboticPlus.AI — RoboticPlus.AI is an robtics company that helps in architectural tech by providing intelligent robotic products for the construction sector.
- Unbounded Dynamics — Unbounded Dynamics is a robotics and embodied intelligence startup focused on developing foundational AI “brains” and operational intelligence for robots and autonomous systems aimed at industrial and B-end scenarios. It works on the coordination of perception (“eyes”), manipulation (“hands”), and decision-making (“brain”) in physical robots bybuilding general basic models and expert system integrations as part of a hardware-software architecture to enable continuous iterative evolution of embodied intelligence.
- HEMO BIOENGINEERING — HEMO BIOENGINEERING develops and provides innovative interventional medical devices to patients.
Tianjin Venture Capital is an investment firm.
Show more...Investment focus
- Industry: Manufacturing, Information Technology, Biotechnology
- Stage:Seed, Series A
- Geography: China, United States
Investor stats
- Total investments: 103
- Round size: Seed $413k–$15M; Series A $202k–$28M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Yuantian Bio — Yuantian Bio is a biotechnology company specializing in enzymatic regeneration and commercial plastic PET applications. They have achieved low-cost fermentation preparation of over 10 enzyme preparations and large-scale biochemical product preparation.
- YolTech Therapeutics — Yaotang (Shanghai) Biotechnology is a high-tech biotechnology company focusing on developing a new generation of mRNA drugs and gene editing drugs by combining mRNA in vivo delivery technology and gene editing technology. Through the continuous development and optimization of CRISPR, base editing and other new-generation gene editing tools, andinnovative improvements to the next-generation mRNA production platform and lipid nanocarrier assembly process, Yaotang Bio is committed to developing treatments for genetic diseases and cardiovascular disease.
- JGene Biotechnology — JGene Biotechnology is a research and development biotechnology company dedicated to the research and development of universal CAR-NK/T products from iPS. It is hoped that the large-scale production of CAR-NK/T from iPS will provide cancer patients with spot-type, price-friendly, and affordable new immune cell therapy products. Recentlyreceived angel round investment.
ULTIMA is an investment management firm.
Show more...Investment focus
- Industry: Hardware, Software, Agriculture
- Stage:Angel, Series A
- Geography: China
Investor stats
- Total investments: 4
- Round size: Series A $1.6M–$14M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Maimai — Maimai provides software and hardware smart care solutions for middle-to-high-end institutions, senior citizens, communities and home care.
- Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.
Bits x Bites is a food tech VC that invests in early-stage startups tackling global food system challenges. It targets companies innovating across the food supply chain, from farming, production, distribution, and logistics, to consumer goods and food services.
Show more...Investment focus
- Industry: Biotechnology, Food and Beverage, Food Processing
- Stage:Series A, Seed, Series B
- Geography: China, Israel, Singapore
Investor stats
- Total investments: 28
- Lead/follow: no public data
Portfolio highlights
- Cataya Bio — Cataya Bio (Shanghai) Co., Ltd. is a product company powered by an advanced engineering biology platform and biomanufacturing. We engineer microbes and develop clean fermentation processes to manufacture products of high purity, at low cost, and in a sustainable way. We strive to help the world to transition away from petroleum and addressimportant global issues in environmental preservation, carbon emission and climate change.
- Ketai Bio — Ketai Bio is a synthetic biology company dedicated to the R&D, production and sales of high value-added bio-based products.
- Changjin Biotechnology — Changjin Biotechnology engages in the research, development, and industrialization of microbial synthetic proteins.
Sherpa Venture Capital is an investment firm that focuses on the investment and cultivation of the Pharmaceutical and Biotech industry. It also specializes in the investment and management of sector leaders and innovators within the Pharma, GeneTech, MedTech, Medical services, and various sub-sectors, where they have established robust portfoliosources, lasting value-adding cooperations and relationships, as well as mature all-cycle services with key resources. It was founded in 2018 and is headquartered in Beijing, China.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: China, United States, Kenya
Investor stats
- Total investments: 97
- Round size: Series A $2.8M–$43M; Series B $14M–$100M; Series C $12M–$156M
- Lead/follow: 28% lead, 72% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- Shenji Bio — Shenji Bio is a developer of POCT diagnostic products and tumor molecular diagnostic products.
- Zion Pharma — Zion is a leading drug discovery platform that develops "me-better" drugs that address true unmet needs.
- Hongyun Biotech — Hongyun Biotech is a biotech company that promotes therapeutic innovation based on structural pharmacology.
Shenzhen Oriental Fortune Capital Co Ltd. is a venture capital firm specializing investment in early venture, mid venture, late venture, emerging growth, Pre-IPO, mature, growth capital stage, mezzanine and new third board investments. The firm typically invests in financial services, telecommunication, new energy, consumer goods, medical treatmentand healthcare, life sciences, internet plus healthy lifestyle industry, logistics, energy technology, information technology, mobile innovation, media, movies and television, culture, pharmaceutical, biological medicine, renewable energy, retail, environmental protection business, consumption, new materials, new agriculture, advanced manufacturing, equipment manufacturing, culture, entertainment, and services. It seeks to invest in China focusing on Shenzhen, Shanghai, Beijing, Xi’an, and Wuhu. The firm also invests in Pearl River Delta region, Yangtze River Delta region, and Circum-Bohai-Sea region. For Pearl River Delta, it covers Guangzhou, Shenzhen, Foshan, Dongguan, Zhongshan, Zhuhai, Huizhou, Jiangmen, and Zhaoqing cities in China. For Yangtze River Delta, the firm covers Shanghai, Nanjing, Wuxi, Changzhou, Suzhou, Nantong, Yancheng, Yangzhou, Zhenjiang, Taizhou, Hangzhou, Ningbo, Jiaxing, Huzhou, Shaoxing, Jinhua, Zhoushan, Taizhou, Hefei, Wuhu, Ma’anshan, Tongling, Anqing, Chuzhou, Chizhou, and Xuancheng cities in China. For the Circum-Bohai-Sea region, it covers Beijing, Tianjin, Shenyang, Dalian, Qingdao, Dandong, Yingkou, Panjin, Fuxin, Huludao, Chaoyang, Shijiazhuang, Baoding, Tangshan, Qinhuangdao, Cangzhou, Langfang, Chengde, Zhangjiakou, Handan, Xingtai, Dongying, Yantai, Weifang, Weihai, Rizhao, and Binzhou cities in China. The firm prefers to invest 20% of its portfolio to early stage, 40% to expansion stage, and 40% to Pre-IPO stage. Shenzhen Oriental Fortune Capital Co Ltd. was formed in November 2007 and is based in Shenzhen, China with offices in Shanghai, China; Beijing, China; and Wuhu, China.
Show more...Investment focus
- Industry: Software, Manufacturing, Information Technology
- Stage:Series A, Series B, Seed
- Geography: China, United States
Investor stats
- Total investments: 221
- Round size: Seed $2.8M–$74M; Series A $1.4M–$30M; Series B $2.9M–$100M
- Lead/follow: 36% lead, 64% follow
- Last fund: May invest from a new fund soon — last raise in 2015
Portfolio highlights
- Spectrum-Dynamics — attenuation correction, deep learning, stress test, CTLC, Nuclear Medicine, Digital SPECT, CZT
- Technological Innovation — Technological Innovation is a provider of brain-computer interface (BCI) technology research and development, as well as application services.
- Photoacoustic Pharmaceuticals — Photoacoustic Pharmaceuticals is an innovative developer of photosensitizers and related products. It is committed to advancing the development of dynamic photoacoustic therapy.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Puhua Capital is an equity investment firm that focuses on early and middle project. Puhua Capital provides the required resources and management experience for the invested enterprise, investing funds and more resources and wisdom. Puhua Capital has invested nearly 300 excellent start-ups.
Show more...Investment focus
- Industry: Health Care, Medical, Manufacturing
- Stage:Series A, Series B, Seed
- Geography: China, United Kingdom, United States
Investor stats
- Total investments: 176
- Round size: Seed $1.4M–$29M; Series A $1.4M–$112M; Series B $2.8M–$100M
- Lead/follow: 32% lead, 68% follow
Portfolio highlights
- Tinychip — Tinychip is a microelectronics chip company that manufactures analog-to-digital hybrid automotive chips.
- WITINMEM — Founded in Oct. 2017, WITINMEM focuses on Low cost, low power AI chips and system solutions based on processing-in-memory technology in NOR Flash memory. This technology performs the inference step of deep neural networks inside the NOR Flash memory that stores the processing weights long term – bringing huge advantages in performance, power, andaccuracy. WITINMEM’s platform frees local AI from the cloud and is committed to the realization of ubiquitous AI smart devices.
- MindMotion — MindMotion is an electronics company that supplies general-purpose 32-bit MCU products and solutions. The company's MM32 MCU products developed by the company based on the Arm Cortex-M series cores have four series of F/L/SPIN/W, more than 200 models, and a cumulative delivery of more than 300 million units, ranking in theforefront of local general-purpose 32-bit MCU companies.MindMotion was founded in 2011 and is headquartered in Shanghai, China.
Our team invests in early-stage digital health and consumer startups at CentreGold Capital.
Show more...Investment focus
- Industry: Medical Device, Internet, Health Care
- Stage:Seed, Series A, Angel
- Geography: United States, China, Canada
Investor stats
- Total investments: 17
- Lead/follow: no public data
Portfolio highlights
- Juix — Juix is a power bank rental service that allows people to charge their devices on the go.
- Virgo — Accelerate GI clinical trials with AI for endoscopy. Use video to automate workflows, improve standard of care, and accelerate results.
- WeBox — Saltalk is a virtual kitchen platform that focuses on Asian Authentic Food optimized for delivery services.
Gaw Capital Partners is a positioned private equity fund management company that focuses in real estate markets in greater China and other high barrier-to-entry markets globally. Their services includes gateway real estate funds, separate account investments, venture capital, private equity investment and credit investments.
Show more...Investment focus
- Industry: Real Estate, Property Management, Hospitality
- Stage:Series A, Series C, Seed
- Geography: China, Singapore, United States
Investor stats
- Total investments: 22
- Lead/follow: no public data
Portfolio highlights
- Blackpanda — Asia's premier digital forensics and cyber incident response firm.
- SARELLY SARELLY — SARELLY SARELLY is a gender-neutral and transparent fashion brand, offering affordable luxury to the Hispanic Gen Z community.
- NPX Point Avenue — NPX Point Avenue is an education technology company focused on the fast-growing K-12 private international school market and K-12 after-school training market.
Haitang Fund is a venture capital fund jointly established by Tianjin University alumni entrepreneurs and other alumni and entrepreneurs.
Show more...Investment focus
- Industry: Manufacturing, Biotechnology, Medical
- Stage:Seed, Series A
- Geography: China
Investor stats
- Total investments: 33
- Lead/follow: no public data
Portfolio highlights
- Scan3D — Scan3D is a high-tech enterprise focusing on the research and development of new materials and intelligent equipment.
- Tianhai Junkang — Tianhai Junkang is an enterprise focusing on the sales of Class II medical devices and related technical services.
- Tianhesheng New Materials — Tianhesheng is a new materials technology company specializing in the development, production, and sales of boron isotope products. They plan to use their latest funding round to enhance research and development as well as expand market growth.
UTEC-The University of Tokyo Edge Capital Partners Co., Ltd.. UTEC is a seed/early stage technology focused venture capital firm associated with The University of Tokyo.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A
- Geography: Japan, United States, India
Investor stats
- Total investments: 172
- Round size: Seed $3.1M–$54M; Series A $5.2M–$85M
- Lead/follow: 37% lead, 63% follow
Portfolio highlights
- ALGO ARTIS — ALGO ARTIS is a software company that offers optimization in plant operations, tanking, ship allocation plan, and logistics.
- SUN METALON — SUN METALON aims to create a world where metal products can be produced from local ores. The company was founded in 2021 and is headquartered in Redondo Beach, California.
- BUGWORKS Research — Bugworks, a clinical stage biopharmaceutical company Harnessing the power of science to develop affordable, accessible, novel therapies against infectious disea
Huimei Capital primarily seeks investment in the medical and healthcare ecosystem in a multi-dimensional and three-dimensional manner. It is committed to building a professional investment platform with international vision and local execution, helping early and growing medical and health companies to grow rapidly.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: China, United States, Japan
Investor stats
- Total investments: 30
- Round size: Series A $10M–$227M; Series B $18M–$99M; Series C $30M–$71M
- Lead/follow: 37% lead, 63% follow
Portfolio highlights
- Sniper Medical Technology — Sniper develops accurate and intelligent molecular diagnostic solutions. Taking the next-generation fully automatic digital PCR as a breakthrough, the company has developed a droplet generation method with global independent intellectual property rights - Vibrant Injection technology and created a new path of chip-free droplet generationtechnology. It solves the pain points of high cost and complicated operation of microfluidic technology in practical application and is expected to bring subversive innovation in the field of refined medical testing.
- Xushui Internet — Xushui Internet provides image equipment monitoring, operation, and maintenance cloud services, large-scale equipment IoT management system, digital integration services for hospital-wide equipment, and remote collaborative image inspection system.
- Chengdu Pukang Biotechnology Co. — Chengdu Pukang Biotechnology Co., Ltd specializes in the development, production, and supply of high-purity single molecular PEG series derivatives, polypeptide long-acting drug side chains, and their intermediates. The company focuses on serving the pharmaceutical industry with a range of chemical supplies that are crucial for drug development andmanufacturing processes. With a professional R&D team, Chengdu Pukang Biotechnology is dedicated to advancing pharmaceutical intermediates technology and providing solutions that meet the evolving needs of the healthcare sector. The company's commitment to research and development is evident in its continuous efforts to innovate and improve its product offerings to support the pharmaceutical industry.
Shunwei Capital is a venture capital fund that focuses on early to mid-stage investments in local internet industry. It specializes in incubation, startups, early to mid-stage, and growth capital investments. It seeks to invest in the technology, media, telecommunications, high technology, new media, games, internet finance, and rural area internetsectors. Their investors include sovereign wealth funds, fund of funds, university endowment funds, and family offices.
Show more...Investment focus
- Industry: Manufacturing, Software, Internet
- Stage:Series A, Series B, Series C
- Geography: China, United States, India
Investor stats
- Total investments: 410
- Round size: Series A $1.4M–$41M; Series B $8.2M–$50M; Series C $20M–$130M
- Lead/follow: 31% lead, 69% follow
- Last fund: May invest from a new fund soon — raised $1.2B in 2018
Portfolio highlights
- Hohem — Hohem is a world-leading brand dedicated to AI tracking gimbals for video shooting, providing consumer and professional stabilizers for smartphones and cameras.
- Z.ai — Z.ai develops artificial intelligence models and services built upon large-scale pretrained architectures. The company offers ChatGLM, a dialogue-focused language model series designed for smooth conversation and easy integration. It also provides Ying, a text-to-video model capable of generating short video clips from text or images, and AutoGLM,a voice-driven AI agent that performs smartphone tasks based on complex user instructions. Z.ai supports integration through an API platform and offers migration assistance for developers moving from other AI ecosystems. The company’s technology stems from research at Tsinghua University’s KEG lab and emphasizes general-purpose cognitive intelligence models.
- Xingmai Innovation — Xingmai Innovation creates, develops, and sells intelligent swimming pool cleaning robots.
BOHE Angel Fund is an investment Fund.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Angel, Series A, Seed
- Geography: China
Investor stats
- Total investments: 12
- Round size: Angel $1.4M–$100M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- QuarkMed — QuarkMed is a nuclear medicine clinical CRO service company.
- PrinoPharma — PrinoPharma focuses on developing novel druggable sites targeting difficult-to-drug or existing druggable targets.
- Yili Pharmaceutical — Yili Pharmaceutical is a pharmaceutical R&D company that mainly engages in biochemical product technology R&D, medical research and experimental development, engineering and technology research and experimental development, and software development.
The Entrepreneurs Fund is a not-for-profit initiative launched by Alibaba Group in 2015 to help entrepreneurs and young graduates realize their dreams and vision. Two separate funds have been set up in Hong Kong and Taiwan respectively to support specific programs in each place.
Show more...Investment focus
- Industry: Software, E-Commerce, Artificial Intelligence
- Stage:Series A, Seed, Series B
- Geography: Hong Kong, Taiwan, United States
Investor stats
- Total investments: 68
- Round size: Seed $510k–$7M; Series A $2M–$68M; Series B $7M–$150M
- Lead/follow: 47% lead, 53% follow
- Last fund: May invest from a new fund soon — raised $130M in 2015
Portfolio highlights
- PanopticAI — PanopticAI is a health system that uses artificial intelligence and signal processing to comprehend the human body and improve health.
- Vpon Holdings — Vpon Holdings is an AI big data analysis and advertising company.
- Ziwu Technology — Ziwu Technology offers the conversion of bio-based waste into sustainable new materials and provides environmentally friendly solutions.
Eisai is a pharmaceutical company that researches and delivers medicines for patients.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series C
- Geography: Japan, United States, China
Investor stats
- Total investments: 14
- Lead/follow: no public data
Portfolio highlights
- Seed Therapeutics — Seed Therapeutics is a biotech company that focuses on harnessing and engineering molecules.
- Casma Therapeutics — Casma Therapeutics is a developer of a natural cellular process of autophagy to open new target areas for drug discovery and development. The company focuses on autophagy system to improve the cellular process of clearing out unwanted proteins, organelles and invading pathogens as well as tries to arrest or reverse the progression of lysosomalstorage disorders, muscle disorders, inflammatory disorders and neurodegeneration, enabling physicians to address unmet medical needs.
- Lifenet Insurance Company — LIFENET INSURANCE COMPANY offers a range of insurance underwriting and asset management solutions. Its insurance products include death, medical, and disability insurance. The company also provides health counselling services. LIFENET INSURANCE COMPANY was founded in October 2006.
FAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Life Science VC Funds in Asia investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 48,091 VC funds investing in Asia Life Science startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!